|
Age, y, median (range)
|
68 (49–91)
|
70 (38–85)
|
0.33
|
|
Sex, male/female
|
18/10
|
30/31
|
0.25
|
|
Final diagnosis
| | |
0.09
|
|
Pancreatic cancer
|
28
|
54
| |
|
Pancreatic neuroendocrine tumor
| |
7
| |
|
SPL size, mm, median (range)
|
25 (15–50)
|
27 (7–82)
|
0.81
|
|
SPL location, head/body or tail
|
11/17
|
27/34
|
0.82
|
|
Lesion resectability, R/UR
|
6/22
|
25/36
|
0.09
|
|
Puncture route, gastric/duodenal
|
20/8
|
42/29
|
1.0
|
|
Puncture number, median (range)
|
3 (2–5)
|
4 (1–8)
|
< 0.01
|
|
Histological specimen, n (%)
|
26 (92.9)
|
42 (68.9)
|
0.015
|
|
Adverse events, n (%)
|
0 (0)
|
2 (3.3)
|
1.0
|
|
Acute pancreatitis, n
| |
1
| |
|
Bleeding, n
| |
1
| |
